The Effect of Neu-P11 on Symptoms in Patients With D-IBS
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Placebo controlled double-blind study with 40 patients who have an diarrhea-predominant IBS,
20 get Neu-P11, 20 get a placebo. Neu-P11 is a, Melatonin receptor-, Serotonin 5-HT- 1A and
5-HT- 1D - agonist and a serotonin 5-HT- 2B - antagonist.